Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.117,64
-0,97%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ Vanda Pharmaceuticals Inc (VNDA) Vanda Pharmaceuticals Inc (VNDA) Notizie

Vanda Pharmaceuticals Inc

VNDA
4,5199
0,0399 (0,89%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/4/202414:05GLOBEShareholder Capital Delivers Letter to Independent Members..
23/4/202401:13PRNUSVanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial..
17/4/202416:21PRNUSVanda Pharmaceuticals Adopts Limited Duration Stockholder..
17/4/202415:02PRNUSVanda Pharmaceuticals Confirms Rejection of Unsolicited..
03/4/202416:25APSBiotech Catches Major Premarket Bid Following FDA Approval
03/4/202400:10PRNUSVanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S...
07/3/202422:31EDGAR2Form 8-K - Current report
06/3/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202413:00PRNUSVanda Pharmaceuticals Announces FDA Update for supplemental..
05/3/202403:14EDGAR2Form 144 - Report of proposed sale of securities
05/3/202403:12EDGAR2Form 144 - Report of proposed sale of securities
05/3/202403:10EDGAR2Form 144 - Report of proposed sale of securities
05/3/202403:08EDGAR2Form 144 - Report of proposed sale of securities
05/3/202403:06EDGAR2Form 144 - Report of proposed sale of securities
21/2/202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:32EDGAR2Form 8-K - Current report
16/2/202422:31EDGAR2Form 8-K/A - Current report: [Amend]
08/2/202413:19EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/2/202422:07EDGAR2Form 8-K - Current report
07/2/202422:02PRNUSVanda Pharmaceuticals Reports Fourth Quarter and Full Year..
05/2/202422:34EDGAR2Form 8-K - Current report
05/2/202414:00PRNUSVanda Pharmaceuticals Announces FDA Update for supplemental..
31/1/202422:30PRNUSVanda Pharmaceuticals to Announce Fourth Quarter and Full..
31/1/202415:00PRNUSVanda Pharmaceuticals Receives FDA Approval to Proceed with..
30/1/202418:35PRNUSCourt Orders FDA to Resolve Vanda Pharmaceuticals' Jet Lag..
30/1/202401:00PRNUSCourt Orders FDA to Resolve Vanda Pharmaceuticals' Jet Lag..
26/1/202404:05PRNUSVanda Pharmaceuticals Announces a U.S. Patent Allowance for..
25/1/202419:07PRNUSVanda Pharmaceuticals announces the publication of an..
23/1/202417:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/1/202415:15PRNUSVanda Pharmaceuticals Receives FDA Approval to Proceed with..
19/1/202422:57DJNVanda Pharma's Trade Secrets Suit Against FDA Moves Forward
19/1/202421:56PRNUSFederal Court Allows Vanda Pharmaceuticals' Lawsuit to..
17/1/202421:46PRNUSVanda Pharmaceuticals announces the publication of Efficacy..
12/1/202418:21PRNUSVanda Pharmaceuticals Comments on FDA's Recently Announced..
04/1/202422:30PRNUSVanda Pharmaceuticals Announces Participation in the J.P...
15/12/202322:15EDGAR2Form 8-K - Current report
07/12/202323:19EDGAR2Form 8-K - Current report
07/12/202313:00PRNUSVanda Pharmaceuticals Acquires U.S. and Canadian Rights to..
05/12/202312:23DJNVanda Pharmaceuticals Shares Rise Premarket on FDA Review of..
05/12/202300:45DJNVanda Pharma Says FDA Accepts New Drug Application for..
05/12/202300:00PRNUSVanda Pharmaceuticals Announces that U.S. Food and Drug..
09/11/202322:30PRNUSVanda Pharmaceuticals Announces Participation at November..
Apertura: 4,57 Min: 4,45 Max: 4,625
Chiusura: 4,48

La tua Cronologia

NASDAQ
VNDA
Vanda Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network